China Neuroblastoma Treatment Market Report & Forecast 2021-2027

China Neuroblastoma Treatment Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Neuroblastoma Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Neuroblastoma Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Neuroblastoma Treatment Overall Market Size
2.1 China Neuroblastoma Treatment Market Size: 2021 VS 2027
2.2 China Neuroblastoma Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroblastoma Treatment Players in China Market
3.2 Top China Neuroblastoma Treatment Companies Ranked by Revenue
3.3 China Neuroblastoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Neuroblastoma Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Neuroblastoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroblastoma Treatment Players in China Market
3.6.1 List of Tier 1 Neuroblastoma Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Neuroblastoma Treatment Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Neuroblastoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Combination Chemotherapy
4.1.3 Monoclonal Antibody Therapy
4.1.4 Vaccine Therapy
4.1.5 Chimeric Antigen Receptor T-Cell Immunotherapy
4.1.6 Oncolytic Virus Therapy
4.2 By Type - China Neuroblastoma Treatment Revenue & Forecasts
4.2.1 By Type - China Neuroblastoma Treatment Revenue, 2016-2021
4.2.2 By Type - China Neuroblastoma Treatment Revenue, 2022-2027
4.2.3 By Type - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Neuroblastoma Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - China Neuroblastoma Treatment Revenue & Forecasts
5.2.1 By Application - China Neuroblastoma Treatment Revenue, 2016-2021
5.2.2 By Application - China Neuroblastoma Treatment Revenue, 2022-2027
5.2.3 By Application - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
6 Neuroblastoma Treatment Companies Profiles
6.1 Seattle Children's
6.1.1 Seattle Children's Company Details
6.1.2 Seattle Children's Business Overview
6.1.3 Seattle Children's Neuroblastoma Treatment Introduction
6.1.4 Seattle Children's Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.1.5 Seattle Children's Recent Developments
6.2 CureSearch
6.2.1 CureSearch Company Details
6.2.2 CureSearch Business Overview
6.2.3 CureSearch Neuroblastoma Treatment Introduction
6.2.4 CureSearch Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.2.5 CureSearch Recent Developments
6.3 Texas Children's
6.3.1 Texas Children's Company Details
6.3.2 Texas Children's Business Overview
6.3.3 Texas Children's Neuroblastoma Treatment Introduction
6.3.4 Texas Children's Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.3.5 Texas Children's Recent Developments
6.4 NANT
6.4.1 NANT Company Details
6.4.2 NANT Business Overview
6.4.3 NANT Neuroblastoma Treatment Introduction
6.4.4 NANT Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.4.5 NANT Recent Developments
6.5 Sino Biopharmaceutical
6.5.1 Sino Biopharmaceutical Company Details
6.5.2 Sino Biopharmaceutical Business Overview
6.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction
6.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.5.5 Sino Biopharmaceutical Recent Developments
6.6 Jiangsu Hengrui Medicine Co.,Ltd.
6.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details
6.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
6.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction
6.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
6.7 Fosun Pharmaceutical
6.7.1 Fosun Pharmaceutical Company Details
6.7.2 Fosun Pharmaceutical Business Overview
6.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction
6.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.7.5 Fosun Pharmaceutical Recent Developments
6.8 Novartis
6.8.1 Novartis Company Details
6.8.2 Novartis Business Overview
6.8.3 Novartis Neuroblastoma Treatment Introduction
6.8.4 Novartis Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.8.5 Novartis Recent Developments
6.9 Juno Therapeutics
6.9.1 Juno Therapeutics Company Details
6.9.2 Juno Therapeutics Business Overview
6.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction
6.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.9.5 Juno Therapeutics Recent Developments
6.10 Kite Pharma
6.10.1 Kite Pharma Company Details
6.10.2 Kite Pharma Business Overview
6.10.3 Kite Pharma Neuroblastoma Treatment Introduction
6.10.4 Kite Pharma Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.10.5 Kite Pharma Recent Developments
6.11 Adaptimmune
6.11.1 Adaptimmune Company Details
6.11.2 Adaptimmune Business Overview
6.11.3 Adaptimmune Neuroblastoma Treatment Introduction
6.11.4 Adaptimmune Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.11.5 Adaptimmune Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Neuroblastoma Treatment Market Opportunities & Trends in China Market
Table 2. Neuroblastoma Treatment Market Drivers in China Market
Table 3. Neuroblastoma Treatment Market Restraints in China Market
Table 4. Key Players of Neuroblastoma Treatment in China Market
Table 5. Top Neuroblastoma Treatment Players in China Market, Ranking by Revenue (2019)
Table 6. China Neuroblastoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Neuroblastoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Neuroblastoma Treatment Product Type
Table 9. List of Tier 1 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Neuroblastoma Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Neuroblastoma Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Neuroblastoma Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Neuroblastoma Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Neuroblastoma Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Neuroblastoma Treatment Revenue (US$, Mn), 2022-2027
Table 17. Seattle Children's Company Details
Table 18. Seattle Children's Business Overview
Table 19. Seattle Children's Neuroblastoma Treatment Product
Table 20. Seattle Children's Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Seattle Children's Recent Developments
Table 22. CureSearch Company Details
Table 23. CureSearch Business Overview
Table 24. CureSearch Neuroblastoma Treatment Product
Table 25. CureSearch Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 26. CureSearch Recent Developments
Table 27. Texas Children's Company Details
Table 28. Texas Children's Business Overview
Table 29. Texas Children's Neuroblastoma Treatment Product
Table 30. Texas Children's Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Texas Children's Recent Developments
Table 32. NANT Company Details
Table 33. NANT Business Overview
Table 34. NANT Neuroblastoma Treatment Product
Table 35. NANT Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 36. NANT Recent Developments
Table 37. Sino Biopharmaceutical Company Details
Table 38. Sino Biopharmaceutical Business Overview
Table 39. Sino Biopharmaceutical Neuroblastoma Treatment Product
Table 40. Sino Biopharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Sino Biopharmaceutical Recent Developments
Table 42. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
Table 43. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 44. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product
Table 45. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 47. Fosun Pharmaceutical Company Details
Table 48. Fosun Pharmaceutical Business Overview
Table 49. Fosun Pharmaceutical Neuroblastoma Treatment Product
Table 50. Fosun Pharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Fosun Pharmaceutical Recent Developments
Table 52. Novartis Company Details
Table 53. Novartis Business Overview
Table 54. Novartis Neuroblastoma Treatment Product
Table 55. Novartis Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Novartis Recent Developments
Table 57. Juno Therapeutics Company Details
Table 58. Juno Therapeutics Business Overview
Table 59. Juno Therapeutics Neuroblastoma Treatment Product
Table 60. Juno Therapeutics Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Juno Therapeutics Recent Developments
Table 62. Kite Pharma Company Details
Table 63. Kite Pharma Business Overview
Table 64. Kite Pharma Neuroblastoma Treatment Product
Table 65. Kite Pharma Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Kite Pharma Recent Developments
Table 67. Adaptimmune Company Details
Table 68. Adaptimmune Business Overview
Table 69. Adaptimmune Neuroblastoma Treatment Product
Table 70. Adaptimmune Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Adaptimmune Recent Developments
List of Figures
Figure 1. Neuroblastoma Treatment Segment by Type
Figure 2. Neuroblastoma Treatment Segment by Application
Figure 3. China Neuroblastoma Treatment Market Overview: 2020
Figure 4. China Neuroblastoma Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Neuroblastoma Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2020
Figure 7. By Type - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 9. Seattle Children's Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CureSearch Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Texas Children's Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. NANT Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sino Biopharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Fosun Pharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Novartis Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Juno Therapeutics Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Kite Pharma Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Adaptimmune Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs